Paratek pharmaceuticals, inc. (PRTK)
Balance Sheet / Yearly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Dec'10
Assets
Current assets
Cash and cash equivalents

124,624

102,302

104,907

129,164

81,219

46,987

89,117

56,082

49,273

35,416

32,995

51,587

62,044

52,962

52,938

87,427

44,143

131,302

146,428

148,742

-

95,856

20,395

16,845

21,361

-

13,642

17,847

29,708

39,368

70,037

48,994

2,319

10,659

4,056

4,898

13,720

Marketable securities

70,166

113,077

120,730

123,183

176,683

203,364

199,130

207,967

-

116,307

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

630

324

788

1,142

266

266

266

266

-

162

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Available-for-sale securities

-

-

-

-

-

-

-

-

135,051

-

130,445

123,751

77,543

75,076

67,854

62,975

68,120

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

-

-

-

-

-

-

-

-

229

-

162

115

127

817

2,879

2,787

2,629

2,443

-

-

-

-

15

35

200

-

200

200

200

200

200

200

200

200

200

200

200

Cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

92,510

-

-

-

-

1,212

-

-

-

-

-

-

-

-

-

-

-

Accounts receivable, net

10,887

8,475

3,976

2,557

2,195

41

22

19

50

5,041

-

-

-

-

230

85

488

-

270

496

391

4,434

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Inventories, net

13,472

11,579

8,826

7,572

1,978

598

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other receivables

1,383

1,108

854

737

304

208

843

866

785

848

-

23

35

323

-

-

-

745

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

15,889

26,557

48,460

-

62,123

59,739

51,368

45,907

28,634

43,239

56,886

51,703

50,016

54,728

54,251

Prepaid advertising

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

244

542

2,259

8,571

-

-

-

0

-

-

-

Prepaid and other current assets

5,844

6,489

5,095

4,329

4,202

3,779

3,152

2,696

2,840

2,712

2,604

2,967

3,050

2,922

3,557

1,862

3,925

7,927

-

-

-

1,039

541

902

1,345

-

3,089

2,911

1,445

920

2,348

2,837

1,937

3,275

1,038

1,169

1,252

Other current assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

8,289

4,788

1,141

-

-

-

-

40

-

-

-

-

-

-

-

-

-

-

-

Total current assets

227,006

243,354

245,176

268,684

266,847

255,243

292,530

267,896

188,228

160,486

166,206

178,443

142,799

132,100

127,458

155,136

119,305

142,417

154,987

154,026

94,042

101,329

36,840

44,339

71,366

1,252

79,298

81,239

84,980

94,966

101,219

95,270

61,342

65,837

55,310

60,995

69,423

Long-term restricted cash

2,261

3,007

2,947

3,107

250

249

250

-

-

250

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

-

-

-

-

-

-

-

250

250

-

250

250

250

250

1,011

1,011

1,011

250

2,735

3,078

2,864

2,946

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term marketable securities

-

-

-

-

-

42,487

22,668

57,096

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Fixed assets, net

1,094

1,227

967

899

1,037

1,173

1,314

1,462

1,583

1,711

1,922

2,038

2,178

1,188

891

1,034

823

779

672

465

177

49

13

20

24

33

51

52

88

128

166

198

250

314

365

438

614

Intangible assets, net

-

-

-

-

-

-

29

50

139

142

229

255

976

1,015

1,055

1,153

1,251

1,349

1,562

-

-

4,814

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Intangible assets, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,675

1,789

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Goodwill

829

829

829

829

829

829

829

829

829

829

829

828

829

829

829

829

829

829

829

829

829

829

-

-

-

-

0

0

2,962

2,962

2,962

2,962

2,962

2,962

2,962

2,962

2,962

Right-of-use assets

2,322

2,514

2,701

2,884

3,062

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other long-term assets

148

148

154

174

419

211

227

245

263

280

298

315

333

350

367

260

276

294

28

28

-

-

-

-

-

-

-

-

-

-

-

-

38

38

808

808

808

Total assets

233,660

251,079

252,774

276,577

272,444

300,192

317,847

327,828

191,292

163,698

169,734

182,129

147,365

135,732

131,611

159,423

123,495

145,918

160,813

160,101

99,701

109,967

36,853

44,359

71,390

1,285

79,349

81,291

88,030

98,056

104,347

98,430

64,592

69,151

59,445

65,203

73,807

Liabilities and Stockholders’ Deficit
Current liabilities
Current portion of Intermezzo reserve

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,321

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of Intermezzo reserve

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,385

-

160

463

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable

663

4,116

3,956

2,511

3,088

2,090

5,108

2,666

3,756

3,555

2,858

3,274

-

4,418

-

-

-

-

-

-

5

-

447

1,044

886

7,482

1,895

376

954

1,001

1,100

1,012

968

987

647

1,191

598

Accounts payable and other accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

7,305

-

12,509

13,849

10,369

6,443

6,737

5,375

-

2,915

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued contract research

-

-

-

-

-

-

-

-

-

-

4,599

5,668

11,274

9,566

7,132

12,324

13,233

11,583

6,709

5,529

-

826

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of Intermezzo reserve

-

-

-

-

-

-

-

-

-

-

-

-

56

56

2,110

-

-

2,476

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued expenses

18,100

16,696

-

-

-

15,619

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7,279

-

2,192

1,448

1,050

4,783

1,165

975

1,151

1,639

2,227

2,036

1,447

2,108

972

1,197

1,393

Other accrued expenses

-

-

20,042

18,598

15,061

-

12,690

8,978

6,938

8,270

8,340

6,083

-

6,372

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued manufacturing

-

-

-

-

-

-

-

-

-

4,964

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued contract manufacturing costs

-

-

-

-

-

-

7,898

6,537

5,064

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of long-term debt

20,751

-

-

-

-

-

-

15,814

7,607

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Derivative liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

21,022

-

-

-

-

-

-

-

-

-

-

-

Prefunding for financing

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,351

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

191

-

-

-

-

-

-

-

-

417

1,042

7,292

Other current liabilities

3,595

3,388

1,020

971

836

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

9

23

42

70

182

244

306

298

365

Total current liabilities

43,109

24,200

25,018

22,080

18,985

17,709

25,696

33,995

23,365

16,789

15,797

15,025

18,635

20,412

21,751

28,494

25,987

20,502

13,606

11,367

7,284

3,741

2,639

2,492

1,936

34,829

3,060

1,351

2,114

2,663

3,369

3,118

2,597

3,339

2,342

3,728

9,648

Long-term debt

240,299

260,728

260,410

260,097

229,241

228,959

228,680

202,717

51,684

59,186

49,079

48,975

39,060

38,974

19,653

19,625

19,595

19,565

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term lease liabilities

1,838

2,095

2,344

2,586

2,822

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

19,536

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Intermezzo reserve, net of current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,310

2,368

2,565

2,850

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contingent obligations

-

-

-

-

-

-

14

25

56

71

84

106

424

655

950

1,120

1,105

1,000

1,580

1,820

1,420

4,560

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

151

-

-

-

-

-

-

-

-

-

-

-

Other liabilities

3,652

3,703

5,608

5,491

5,365

5,946

5,827

5,599

5,420

5,174

4,902

4,639

4,437

4,099

3,785

3,728

3,669

3,611

3,557

3,557

3,584

3,592

-

-

-

73

-

-

-

-

-

-

39

60

94

177

348

Total liabilities

288,898

290,726

293,380

290,254

256,413

252,614

260,217

242,336

80,525

81,220

69,862

68,745

62,556

64,140

46,139

52,967

50,356

44,678

40,589

19,112

14,853

14,743

-

-

-

35,053

-

-

-

-

3,369

3,118

2,636

3,399

2,436

3,905

9,996

Commitments and contingencies (Note 17)

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

-

-

0

-

-

0

Convertible preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

80,565

-

-

-

-

-

-

-

-

-

-

-

Stockholders’ deficit
Undesignated preferred stock: $0.001 par value; 5,000,000 authorized; no shares issued and outstanding

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

-

-

0

0

0

0

-

-

-

-

0

-

-

-

0

-

-

-

0

-

-

0

Series A Junior participating preferred stock: $0.001 par value; 1,000,000 shares authorized at December 31, 2013; no shares issued and outstanding at December 31, 2013. No shares were authorized, issued or outstanding at December 31, 2012.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

Common stock, $0.001 par value, 100,000,000 shares authorized, 42,374,026 and 39,827,749 issued and outstanding at March 31, 2020 and December 31, 2019, respectively

42

40

33

32

32

32

32

32

31

28

28

28

26

23

23

22

18

17

18

18

14

14

19

19

19

-

19

19

19

19

19

19

14

14

14

14

13

Additional paid-in capital

683,124

671,497

643,106

637,354

634,005

630,142

617,604

613,279

608,776

552,720

548,144

540,347

493,550

451,947

439,344

436,681

373,118

369,949

367,826

365,169

293,333

293,076

188,078

187,525

211,775

65,698

210,260

209,248

208,500

207,477

206,509

205,706

167,213

165,803

162,349

161,642

160,010

Accumulated other comprehensive income

471

74

148

216

72

-128

-329

-226

-180

-158

-80

-96

-54

-16

14

34

1

-

-

-

-

-

4

9

20

-

31

-9

7

7

6

-2

-

29

36

41

2

Accumulated deficit

-738,875

-711,258

-683,893

-651,279

-618,078

-582,468

-559,677

-527,593

-497,860

-470,112

-448,220

-426,895

-408,713

-380,362

-353,909

-330,281

-299,998

-268,726

-247,620

-224,198

-208,499

-197,866

-153,887

-145,686

-142,360

-180,031

-134,021

-129,318

-122,610

-112,110

-105,556

-110,411

-105,271

-100,094

-105,390

-100,399

-96,214

Total stockholders’ deficit

-55,238

-39,647

-40,606

-13,677

16,031

47,578

57,630

85,492

110,767

82,478

99,872

113,384

84,809

71,592

85,472

106,456

73,139

101,240

120,224

140,989

84,848

95,224

34,214

41,867

69,454

-114,333

76,289

79,940

85,916

95,393

100,978

95,312

61,956

65,752

57,009

61,298

63,811

Total liabilities and stockholders’ deficit

233,660

251,079

252,774

276,577

272,444

300,192

317,847

327,828

191,292

163,698

169,734

182,129

147,365

135,732

131,611

159,423

123,495

145,918

160,813

160,101

99,701

109,967

36,853

44,359

71,390

1,285

79,349

81,291

88,030

98,056

104,347

98,430

64,592

69,151

59,445

65,203

73,807